Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents

Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni, David A. Sallman, Qianxing Mo, Onyee Chan, Ling Zhang, Nicole D. Vincelette, Xiaoqing Yu, Rinzine Sammut, Jungwon Moon, Junyoung Park, Sura-Attha Umasangtongkul, Felyschia M. Lledo, Tiffany N. Razabdouski, Chia-Ho Cheng, Dahui Qin, Kathy Mai, Somedeb Ball, Rory M. Shallis, Zhuoer Xie, Andrew T. Kuykendall, Eric Padron, Kendra Sweet, Alison R. Walker, Rami S. Komrokji, Jeffrey E. Lancet, Sandrine Niyongere, Thomas Cluzeau, Seongseok Yun

Open source

DOI
10.1158/2643-3230.bcd-25-0193
Published
2026-02-11
Container
Blood Cancer Discovery
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/2643-3230.bcd-25-0193,
  title = {Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents},
  author = {Dimitrios Drekolias and Fatima Tuz Zahra and Caroline Fileni and David A. Sallman and Qianxing Mo and Onyee Chan and Ling Zhang and Nicole D. Vincelette and Xiaoqing Yu and Rinzine Sammut and Jungwon Moon and Junyoung Park and Sura-Attha Umasangtongkul and Felyschia M. Lledo and Tiffany N. Razabdouski and Chia-Ho Cheng and Dahui Qin and Kathy Mai and Somedeb Ball and Rory M. Shallis and Zhuoer Xie and Andrew T. Kuykendall and Eric Padron and Kendra Sweet and Alison R. Walker and Rami S. Komrokji and Jeffrey E. Lancet and Sandrine Niyongere and Thomas Cluzeau and Seongseok Yun},
  year = {2026},
  journal = {Blood Cancer Discovery},
  doi = {10.1158/2643-3230.bcd-25-0193},
  url = {https://doi.org/10.1158/2643-3230.bcd-25-0193}
}

RIS

TY  - JOUR
TI  - Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents
AU  - Dimitrios Drekolias
AU  - Fatima Tuz Zahra
AU  - Caroline Fileni
AU  - David A. Sallman
AU  - Qianxing Mo
AU  - Onyee Chan
AU  - Ling Zhang
AU  - Nicole D. Vincelette
AU  - Xiaoqing Yu
AU  - Rinzine Sammut
AU  - Jungwon Moon
AU  - Junyoung Park
AU  - Sura-Attha Umasangtongkul
AU  - Felyschia M. Lledo
AU  - Tiffany N. Razabdouski
AU  - Chia-Ho Cheng
AU  - Dahui Qin
AU  - Kathy Mai
AU  - Somedeb Ball
AU  - Rory M. Shallis
AU  - Zhuoer Xie
AU  - Andrew T. Kuykendall
AU  - Eric Padron
AU  - Kendra Sweet
AU  - Alison R. Walker
AU  - Rami S. Komrokji
AU  - Jeffrey E. Lancet
AU  - Sandrine Niyongere
AU  - Thomas Cluzeau
AU  - Seongseok Yun
PY  - 2026
JO  - Blood Cancer Discovery
DO  - 10.1158/2643-3230.bcd-25-0193
UR  - https://doi.org/10.1158/2643-3230.bcd-25-0193
ER  - 

APA

Drekolias, D., Zahra, F. T., Fileni, C., Sallman, D. A., Mo, Q., Chan, O., Zhang, L., Vincelette, N. D., Yu, X., Sammut, R., Moon, J., Park, J., Umasangtongkul, S., Lledo, F. M., Razabdouski, T. N., Cheng, C., Qin, D., Mai, K., Ball, S., Shallis, R. M., Xie, Z., Kuykendall, A. T., Padron, E., Sweet, K., Walker, A. R., Komrokji, R. S., Lancet, J. E., Niyongere, S., Cluzeau, T., & Yun, S. (2026). Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents. Blood Cancer Discovery. https://doi.org/10.1158/2643-3230.bcd-25-0193

Source records